| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Strategy Officer | EVP, Chief Strategy Officer
1 company
Krassan Mitchell is a Chief Strategy Officer at TherapeuticsMD, Inc.. Recent SEC Form 4 filings include 0 buys and 3 sells.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 3, 2020 | TXMD Therapeuticsmd, Inc. | Chief Strategy Officer | Sale+OE | 300,000 | $2.26 | $676,920.00 | -100% | |
| Jun 8, 2015 | TXMD Therapeuticsmd, Inc. | EVP, Chief Strategy Officer | Sale+OE | 30,000 | $8.18 | $245,400.00 | -100% | |
| May 20, 2015 | TXMD Therapeuticsmd, Inc. | EVP, Chief Strategy Officer | Sale+OE | 60,000 | $6.56 | $393,354.00 | -100% |